Subjective Comfort With Multipurpose Care Solutions in Soft Contact Lens Wearers
This study has been completed.
Sponsor:
Alcon Research
Information provided by (Responsible Party):
Alcon Research
ClinicalTrials.gov Identifier:
NCT01211535
First received: September 28, 2010
Last updated: October 15, 2012
Last verified: October 2012
- Full Text View
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study was to assess the comfort of OPTI-FREE RepleniSH in soft contact lens wearers.
| Condition | Intervention |
|---|---|
|
Myopia Astigmatism Refractive Error |
Device: OPTI-FREE RepleniSH multipurpose solution Device: ReNu Biotrue multipurpose solution Device: Silicone hydrogel contact lenses |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Supportive Care |
| Official Title: | Subjective Comfort With Multipurpose Care Solutions in Soft Contact Lens Wearers |
Resource links provided by NLM:
Further study details as provided by Alcon Research:
Primary Outcome Measures:
- Change From Baseline (Day 0) in Ocular Comfort Rating at Day 14 [ Time Frame: Baseline (Day 0), Day 14 ] [ Designated as safety issue: No ]Ocular comfort was rated by the participant on a continuous visual analog scale from 0-100, where 0=extremely uncomfortable, 50=neither comfortable nor uncomfortable, and 100=extremely comfortable. The participant marked a horizontal line across the scale at the point that best described, "how your eyes feel right now." A positive number indicates increased ocular comfort; a negative number indicates decreased ocular comfort.
| Enrollment: | 104 |
| Study Start Date: | September 2010 |
| Study Completion Date: | November 2010 |
| Primary Completion Date: | November 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: OPTI-FREE RepleniSH
OPTI-FREE RepleniSH multipurpose solution used with study contact lenses on a daily wear basis for 14 days
|
Device: OPTI-FREE RepleniSH multipurpose solution
FDA-approved, multipurpose solution used as indicated for cleaning, rinsing, conditioning, disinfecting, and storing study contact lenses on a daily wear basis for 14 days
Other Name: OPTI-FREE® RepleniSH®
Device: Silicone hydrogel contact lenses
Silicone hydrogel contact lenses per subject's habitual brand and prescription worn on a daily wear basis for 14 days, with either OPTI-FREE RepleniSH or ReNu Biotrue used for contact lens care
|
|
Active Comparator: ReNu Biotrue
ReNu Biotrue multipurpose solution used with study contact lenses on a daily wear basis for 14 days
|
Device: ReNu Biotrue multipurpose solution
FDA-approved, multipurpose solution used as indicated for cleaning, disinfecting, daily protein removing, and storing study contact lenses on a daily wear basis for 14 days
Other Name: ReNu Biotrue™
Device: Silicone hydrogel contact lenses
Silicone hydrogel contact lenses per subject's habitual brand and prescription worn on a daily wear basis for 14 days, with either OPTI-FREE RepleniSH or ReNu Biotrue used for contact lens care
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Currently wearing silicone hydrogel contact lenses on a daily wear basis;
- Currently using OPTI-FREE RepleniSH contact lens solution;
- Generally healthy;
- Normal ocular health;
- Willing to follow study procedures and visit schedule;
- Sign Informed Consent and privacy document;
- Other protocol-defined inclusion criteria may apply.
Exclusion Criteria:
- Use of additional lens cleaners;
- Known sensitivities to any ingredient in either test article;
- Systemic or ocular disease or disorder that would negatively affect the conduct or outcome of the study;
- History of ocular surgery/trauma within the last 6 months;
- Any topical ocular or systemic antibiotics within 7 days of enrollment continuing throughout the study;
- Participation in any other ophthalmic drug or device clinical trial within 30 days of enrollent;
- Other protocol-defined exclusion criteria may apply.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Alcon Research |
| ClinicalTrials.gov Identifier: | NCT01211535 History of Changes |
| Other Study ID Numbers: | SMA-09-59 |
| Study First Received: | September 28, 2010 |
| Results First Received: | October 15, 2012 |
| Last Updated: | October 15, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Alcon Research:
|
Soft contact lenses Multi-purpose Solution |
Additional relevant MeSH terms:
|
Astigmatism Myopia Refractive Errors Eye Diseases |
ClinicalTrials.gov processed this record on May 22, 2013